| Period Ending | 31-Mar-2013 | 31-Dec-2012 | 30-Sep-2012 | 30-Jun-2012 |
|---|
|
Total Revenue
|
347,066
|
350,963
|
360,694
|
369,956
| | Cost of Revenue | 212,638 | 214,631 | 203,658 | 212,466 | | |
Gross Profit
|
134,428
|
136,332
|
157,036
|
157,490
| |
|
Operating Expenses |
|
Research Development | 50,978 | 49,994 | 37,802 | 38,240 |
|
Selling General and Administrative | 104,232 | 104,350 | 90,412 | 92,291 |
|
Non Recurring |
-
|
-
| 11,101 |
-
|
|
Others | 7,501 | 8,588 | 8,537 | 9,255 |
|
|
|
Total Operating Expenses |
-
|
-
| 147,852 |
-
| | | |
Operating Income or Loss
|
(28,283)
|
(26,600)
|
9,184
|
17,704
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 8,131 | 759 | (15,845) | 150 |
|
Earnings Before Interest And Taxes | (20,152) | (25,841) | (6,661) | 17,854 |
|
Interest Expense | 4,637 | 4,257 | 3,718 | 4,358 |
|
Income Before Tax | (24,789) | (30,098) | (10,379) | 13,496 |
|
Income Tax Expense | (13,197) | (5,776) | (19,754) | 5,515 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (11,592) | (24,322) | 9,375 | 7,981 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(11,592)
|
(24,322)
|
9,375
|
7,981
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(11,592)
|
(24,322)
|
9,375
|
7,981
|
|
0.09(0.64%) 10:38PM - Nasdaq Real Time Price